A novel and generalizable organotypic slice platform to evaluate stem cell potential for targeting pediatric brain tumors

Cancer Cell International

Volumn 8, Issue , 2008, Pages 9-

  Li, Shengwen Calvin ^a,b,c,d   Loudon, William Gunter ^a,b  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE; TEMODOR; TEMOZOLOMIDE; THIOTEPA;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD BRAIN BARRIER; BONE MARROW CELL; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER STEM CELL; CANCER SURVIVAL; CELL BASED GENE THERAPY; CELL DIFFERENTIATION; CELL MIGRATION; CELL POPULATION; CHILD CARE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; CULTURE MEDIUM; DRUG MEGADOSE; DRUG PENETRATION; EVENING DOSAGE; FEBRILE NEUTROPENIA; GENE DELIVERY SYSTEM; GLIOBLASTOMA; GLIOMA; HUMAN; LIVER TOXICITY; MUCOSA INFLAMMATION; NEPHROTOXICITY; NERVE FIBER GROWTH; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PREDICTION; STEM CELL TRANSPLANTATION; SYNAPTIC POTENTIAL; TARGET CELL; UNSPECIFIED SIDE EFFECT;

EID: 48249112190     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-8-9     Document Type: Article

References (43)

1. Bradley S Sherwood PR Donovan HS Hamilton R Rosenzweig M Hricik A Newberry A Bender C I could lose everything: Understanding the cost of a brain tumor J Neurooncol 2007, 85(3):329-338. 10.1007/s11060-007-9425-0 17581698
2. Fisk GJ Inokuma MS Endoderm cells from human embryonic stem cells. United States Patent US7326572B2 USA, Geron Corporation 2008, 1-40.
3. Kutikova L Bowman L Chang S Long SR Thornton DE Crown WH Utilization and cost of health care services associated with primary malignant brain tumors in the United States J Neurooncol 2007, 81(1):61-65. 10.1007/ s11060-006-9197-y 16773215
4. Louis DN Molecular pathology of malignant gliomas Annu Rev Pathol 2006, 1;97-117. 10.1146/annurev.pathol.1.110304.100043 18039109
5. Knab B Connell PP Radiotherapy for pediatric brain tumors: When and how Expert Rev Anticancer Ther 2007, 7(12 Suppl):S69-77. 10.1586/ 14737140.7.12s.S69 18076312
6. Loudon WG Sutton LN Childhood Malignant Gliomas. Contemporary Neurosurgery 2000 22; 19:1-9.
7. Briere ME Scott JG McNall-Knapp RY Adams RL Cognitive outcome in pediatric brain tumor survivors: Delayed attention deficit at long-term follow-up Pediatr Blood Cancer 2008, 50(2):337-340. 10.1002/pbc.21223 17458873
8. Meeske KA Patel SK Palmer SN Nelson MB Parow AM Factors associated with health-related quality of life in pediatric cancer survivors Pediatr Blood Cancer 2007, 49(3):298-305. 10.1002/pbc.20923 16779805
9. Zebrack BJ Gurney JG Oeffinger K Whitton J Packer RJ Mertens A Turk N Castleberry R Dreyer Z Robison LL Zeltzer LK Psychological outcomes in long-term survivors of childhood brain cancer: A report from the childhood cancer survivor study J Clin Oncol 2004, 22(6):999-1006. 10.1200/JCO.2004.06.148 15020603
10. Benesch M Lackner H Moser A Kerbl R Schwinger W Oberbauer R Eder HG Mayer R Wiegele K Urban C Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas Pediatr Neurosurg 2001, 35(4):173-180. 10.1159/000050418 11694794
11. Foreman NK Faestel PM Pearson J Disabato J Poole M Wilkening G Arenson EB Greffe B Thorne R Health status in 52 long-term survivors of pediatric brain tumors J Neurooncol 1999, 41(1):47-53. 10.1023/ A:1006145724500 10222422
12. Sanai N Mirzadeh Z Berger MS Functional outcome after language mapping for glioma resection N Engl J Med 2008, 358(1):18-27. 10.1056/ NEJMoa067819 18172171
13. Vernooij MW Ikram MA Tanghe HL Vincent AJ Hofman A Krestin GP Niessen WJ Breteler MM van der Lugt A Incidental findings on brain MRI in the general population N Engl J Med 2007, 357(18):1821-1828. 10.1056/ NEJMoa070972 17978290
14. Partap S Fisher PG Update on new treatments and developments in childhood brain tumors Curr Opin Pediatr 2007, 19(6):670-674. 18025934
15. Muller FJ Snyder EY Loring JF Gene therapy: Can neural stem cells deliver? Nat Rev Neurosci 2006, 7(1):75-84. 10.1038/nrn1829 16371952
16. Bierings M Nachman JB Zwaan CM Stem cell transplantation in pediatric leukemia and myelodysplasia: State of the art and current challenges Curr Stem Cell Res Ther 2007, 2(1):53-63. 10.2174/157488807779317035 18240454
17. Mapara KY Stevenson CB Thompson RC Ehtesham M Stem cells as vehicles for the treatment of brain cancer Neurosurg Clin N Am 2007, 18(1):71-80, ix. 10.1016/j.nec.2006.10.001 17244555
18. Sagar J Chaib B Sales K Winslet M Seifalian A Role of stem cells in cancer therapy and cancer stem cells: A review Cancer Cell Int 2007, 7:9. 1894783 17547749 10.1186/1475-2867-7-9
19. Aboody KS Brown A Rainov NG Bower KA Liu S Yang W Small JE Herrlinger U Ourednik V Black PM Breakefield XO Snyder EY Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas Proc Natl Acad Sci U S A 2000, 97(23):12846-12851. 18852 11070094 10.1073/pnas.97.23.12846
20. Glass R Synowitz M Kronenberg G Walzlein JH Markovic DS Wang LP Gast D Kiwit J Kempermann G Kettenmann H Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival J Neurosci 2005, 25(10):2637-2646. 10.1523/JNEUROSCI.5118-04.2005 15758174
21. Synowitz M Kiwit J Kettenmann H Glass R Tumor Young Investigator Award: tropism and antitumorigenic effect of endogenous neural precursors for gliomas Clin Neurosurg 2006, 53:336-344. 17380772
22. Benedetti S Pirola B Pollo B Magrassi L Bruzzone MG Rigamonti D Galli R Selleri S Di MF De FC Vescovi A Cattaneo E Finocchiaro G Gene therapy of experimental brain tumors using neural progenitor cells NatMed 2000, 6(4):447-450.
23. Birnbaum T Roider J Schankin CJ Padovan CS Schichor C Goldbrunner R Straube A Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines J Neurooncol 2007, 83(3):241-247. 10.1007/s11060-007-9332-4 17570034
24. Sonabend AM Dana K Lesniak MS Targeting epidermal growth factor receptor variant III: A novel strategy for the therapy of malignant glioma Expert Rev Anticancer Ther 2007, 7(12 Suppl):S45-50. 10.1586/14737140.7.12s.S45 18076318
25. Sonabend AM Ulasov IV Tyler MA Rivera AA Mathis JM Lesniak MS Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma Stem Cells 2008 18192232
26. Studeny M Marini FC Champlin RE Zompetta C Fidler IJ Andreeff M Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors Cancer Res 2002, 62(13):3603-3608. 12097260
27. Yuan X Hu J Belladonna ML Black KL Yu JS Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma Cancer Res 2006, 66(5):2630-2638. 10.1158/ 0008-5472.CAN-05-1682 16510582
28. Cheuk DK Lee TL Chiang AK Ha SY Chan GC Autologous hematopoietic stem cell transplantation for high-risk brain tumors in children J Neurooncol 2008, 86(3):337-347. 10.1007/s11060-007-9478-0 17906911
29. Chen HI Bakshi A Royo NC Magge SN Watson DJ Neural stem cells as biological minipumps: A faster route to cell therapy for the CNS? Curr Stem Cell Res Ther 2007, 2(1):13-22. 10.2174/157488807779317044 18220888
30. Ben-Hur T Human embryonic stem cells for neuronal repair Isr Med Assoc J 2006, 8(2):122-126. 16544737
31. Phinney DG Prockop DJ Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair--current views Stem Cells 2007, 25(11):2896-2902. 10.1634/ stemcells.2007-0637 17901396
32. Kioi M Husain SR Croteau D Kunwar S Puri RK Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy Technol Cancer Res Treat 2006, 5(3):239-250. 16700620
33. Mimeault M Hauke R Batra SK Stem cells: A revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies Clin Pharmacol Ther 2007, 82(3):252-264. 10.1038/sj.clpt.6100301 17671448
34. Lee JP Jeyakumar M Gonzalez R Takahashi H Lee PJ Baek RC Clark D Rose H Fu G Clarke J McKercher S Meerloo J Muller FJ Park KI Butters TD Dwek RA Schwartz P Tong G Wenger D Lipton SA Seyfried TN Platt FM Snyder EY Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease Nat Med 2007, 13(4):439-447. 10.1038/ nm1548 17351625
35. Isakova IA Baker K DuTreil M Dufour J Gaupp D Phinney DG Age- and dose-related effects on MSC engraftment levels and anatomical distribution in the central nervous systems of nonhuman primates: identification of novel MSC subpopulations that respond to guidance cues in brain Stem Cells 2007, 25(12):3261-3270. 10.1634/stemcells.2007-0543 17932418
36. Weidt C Niggemann B Kasenda B Drell TL Zanker KS Dittmar T Stem cell migration: A quintessential stepping stone to successful therapy Curr Stem Cell Res Ther 2007, 2(1);89-103. 10.2174/157488807779317008 18220894
37. Imitola J Raddassi K Park KI Mueller FJ Nieto M Teng YD Frenkel D Li J Sidman RL Walsh CA Snyder EY Khoury SJ Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/ CXC chemokine receptor 4 pathway Proc Natl Acad Sci U S A 2004, 101(52):18117-18122. 536055 15608062 10.1073/pnas.0408258102
38. Ries C Egea V Karow M Kolb H Jochum M Neth P MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines Blood 2007, 109(9):4055-4063. 10.1182/blood-2006-10-051060 17197427
39. Wynn RF Hart CA Corradi-Perini C O'Neill L Evans CA Wraith JE Fairbairn LJ Bellantuono I A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow Blood 2004, 104(9):2643-2645. 10.1182/ blood-2004-02-0526 15251986
40. Sordi V Malosio ML Marchesi F Mercalli A Melzi R Giordano T Belmonte N Ferrari G Leone BE Bertuzzi F Zerbini G Allavena P Bonifacio E Piemonti L Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets Blood 2005, 106(2):419-427. 10.1182/ blood-2004-09-3507 15784733
41. Weidt C Niggemann B Hatzmann W Zanker KS Dittmar T Differential effects of culture conditions on the migration pattern of stromal cell-derived factor-stimulated hematopoietic stem cells Stem Cells 2004, 22(6):890-896. 10.1634/stemcells.22-6-890 15536181
42. Niggemann B Drell TL Joseph J Weidt C Lang K Zaenker KS Entschladen F Tumor cell locomotion: Differential dynamics of spontaneous and induced migration in a 3D collagen matrix Exp Cell Res 2004, 298(1):178-187. 10.1016/j.yexcr.2004.04.001 15242772
43. Lin D Najbauer J Salvaterra PM Mamelak AN Barish ME Garcia E Metz MZ Kendall SE Bowers M Kateb B Kim SU Johnson M Aboody KS Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma Neuroimage 2007, 37(Suppl 1):S18-26. 10.1016/ j.neuroimage.2007.03.076 17560798